APA (7th ed.) Citation

Minckwitz, G. v., Huang, C., Mano, M. S., Loibl, S., Mamounas, E. P., Untch, M., . . . Geyer, C. E. (2019). Trastuzumab emtansine for residual invasive HER2-positive breast cancer. The New England journal of medicine, 380(7), . https://doi.org/10.1056/NEJMoa1814017

Chicago Style (17th ed.) Citation

Minckwitz, Gunter von, et al. "Trastuzumab Emtansine for Residual Invasive HER2-positive Breast Cancer." The New England Journal of Medicine 380, no. 7 (2019). https://doi.org/10.1056/NEJMoa1814017.

MLA (9th ed.) Citation

Minckwitz, Gunter von, et al. "Trastuzumab Emtansine for Residual Invasive HER2-positive Breast Cancer." The New England Journal of Medicine, vol. 380, no. 7, 2019, https://doi.org/10.1056/NEJMoa1814017.